Moreover, frequency of rearrangements at MiDAS sites identified in BRCA2-deficient cells was markedly higher in the tumors with BRCA2 mutations than the tumors with wild-type BRCA2 (Figure 6F), supporting the premise that TRCs and R-loops drive genomic instability in human cancers lacking HR. The gene discussed is BRCA2; the disease is cancer.